NAUSHAD PERVEZ

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ALLEN PARK, MI NPI 1962403170

General Payments — all program years on this page

$5,371.81

Category: General Payments
Program years: PY2018–2024
Record count: 271
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,394.38 across 52 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,331.66	49
Education	$62.72	3

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Acerta Pharma LLC	$448.30	17
ANI Pharmaceuticals, Inc.	$179.08	4
Boehringer Ingelheim Pharmaceuticals, Inc.	$133.05	5
Ardelyx, Inc.	$101.87	5
Exact Sciences Corporation	$93.39	1
Retrophin, Inc.	$87.38	4
Amgen Inc.	$86.37	4
NOVARTIS PHARMACEUTICALS CORPORATION	$82.85	3
OPKO Pharmaceuticals, LLC	$38.11	2
Otsuka America Pharmaceutical, Inc.	$29.45	1
AKEBIA THERAPEUTICS INC	$24.61	1
CALLIDITAS THERAPEUTICS US INC.	$22.66	1
Fresenius USA Marketing, Inc.	$21.76	1
Aurinia Pharma U.S., Inc.	$16.65	1
Lilly USA, LLC	$14.53	1
Daiichi Sankyo Inc.	$14.32	1

By program year

Program year	Amount	Records
2018	$634.16	32
2019	$722.08	42
2020	$330.77	24
2021	$595.97	36
2022	$767.24	39
2023	$927.21	46
2024	$1,394.38	52

Records — PY2024 (52)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1087322367	Novartis Pharmaceuticals Corporation	$25.78	02/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087322375	Novartis Pharmaceuticals Corporation	$29.52	04/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1087322377	Novartis Pharmaceuticals Corporation	$27.55	08/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1089468966	Daiichi Sankyo Inc.	$14.32	02/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091134523	ANI Pharmaceuticals, Inc.	$104.10	10/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091137142	ANI Pharmaceuticals, Inc.	$12.24	05/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091137772	ANI Pharmaceuticals, Inc.	$33.78	07/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1091142456	ANI Pharmaceuticals, Inc.	$28.96	09/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104301814	AstraZeneca Pharmaceuticals LP	$22.70	07/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104313740	AstraZeneca Pharmaceuticals LP	$17.94	03/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104330574	AstraZeneca Pharmaceuticals LP	$24.42	01/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104376813	AstraZeneca Pharmaceuticals LP	$26.29	10/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104558414	AstraZeneca Pharmaceuticals LP	$32.84	11/18/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104560246	AstraZeneca Pharmaceuticals LP	$41.11	02/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104593566	AstraZeneca Pharmaceuticals LP	$25.97	04/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104635935	AstraZeneca Pharmaceuticals LP	$29.75	10/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104775914	AstraZeneca Pharmaceuticals LP	$20.41	05/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104784092	AstraZeneca Pharmaceuticals LP	$25.39	08/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105257867	AstraZeneca Pharmaceuticals LP	$27.07	05/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105477953	AstraZeneca Pharmaceuticals LP	$27.97	02/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105659418	AstraZeneca Pharmaceuticals LP	$19.34	03/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105660218	AstraZeneca Pharmaceuticals LP	$30.85	09/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105667000	AstraZeneca Pharmaceuticals LP	$30.12	03/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105713936	AstraZeneca Pharmaceuticals LP	$18.63	07/31/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105827887	AstraZeneca Pharmaceuticals LP	$27.50	08/29/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1112848338	OPKO Pharmaceuticals, LLC	$19.27	02/07/2024	Education	Undisputed	01/23/2026	View at CMS
1112848340	OPKO Pharmaceuticals, LLC	$18.84	05/29/2024	Education	Undisputed	01/23/2026	View at CMS
1114832823	Exact Sciences Corporation	$93.39	08/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1116012795	Amgen Inc.	$17.92	12/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1116012801	Amgen Inc.	$20.16	12/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117654132	Amgen Inc.	$17.18	04/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117654134	Amgen Inc.	$31.11	06/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118251423	Boehringer Ingelheim Pharmaceuticals, Inc.	$21.48	02/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118251425	Boehringer Ingelheim Pharmaceuticals, Inc.	$21.61	06/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118251427	Boehringer Ingelheim Pharmaceuticals, Inc.	$29.05	01/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118251429	Boehringer Ingelheim Pharmaceuticals, Inc.	$30.11	09/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118251431	Boehringer Ingelheim Pharmaceuticals, Inc.	$30.80	10/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118960505	Otsuka America Pharmaceutical, Inc.	$29.45	07/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1135273681	Lilly USA, LLC	$14.53	11/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1141512781	CALLIDITAS THERAPEUTICS US INC.	$22.66	04/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1145833749	AKEBIA THERAPEUTICS INC	$24.61	10/21/2024	Education	Undisputed	01/23/2026	View at CMS
1146700848	Ardelyx, Inc.	$22.26	03/14/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146700850	Ardelyx, Inc.	$15.47	04/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146700852	Ardelyx, Inc.	$24.30	07/11/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146700854	Ardelyx, Inc.	$19.38	09/04/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146700856	Ardelyx, Inc.	$20.46	11/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149942730	Travere Therapeutics, Inc.	$19.61	01/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149942734	Travere Therapeutics, Inc.	$20.74	04/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149942738	Travere Therapeutics, Inc.	$20.89	11/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149942742	Travere Therapeutics, Inc.	$26.14	07/24/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1150689607	Aurinia Pharma U.S., Inc.	$16.65	03/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154203336	Fresenius USA Marketing, Inc.	$21.76	07/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.